MedTech Investment: How Pioneer Group Is Supporting The Game-Changers Of TomorrowAmy Cotterill2024-11-28T16:42:01+00:00May 23rd, 2023|Accelerator, BioCity Nottingham, Investment, MediCity Nottingham|
Pioneer Group Adds NunaBio To Venture Building ProgrammeVicky Coghlan2024-11-28T14:45:20+00:00April 21st, 2023|Investment, News|
Life Science Accelerator Programme: How Cutting-Edge Companies Are Growing Organically At BioCity NottinghamAmy Cotterill2024-11-28T14:46:11+00:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
NanoSyrinx Joins Life Sciences Incubator In NottinghamAmy Cotterill2024-11-28T14:47:44+00:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Life Sciences Investment Showcase: Connecting Entrepreneurs With Expert Growth FacilitatorsAmy Cotterill2025-05-19T11:40:04+01:00March 23rd, 2023|Accelerator, Article, Investment|
Life Sciences Investing: Pioneer Group Reinvests In Biotech Firm NuVisionVicky Coghlan2024-11-28T14:48:12+00:00March 9th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Five Questions With Harry Pickering, Portfolio Director & Head Of UK InvestmentVicky Coghlan2024-11-28T14:48:26+00:00February 21st, 2023|Article, Headline Article, Investment|
Pioneer Group Announce Lead Investment In Selentus ScienceVicky Coghlan2024-11-28T14:49:26+00:00February 7th, 2023|BioCity Nottingham, Investment, News|
Amphista Therapeutics Enters Strategic Collaboration With Bristol Myers SquibbGemma Cann2024-11-28T14:54:56+00:00May 4th, 2022|BioCity Glasgow, Investment, News|
Life Science Start-Up Report 2022 Launched By Pioneer Group And JLLGemma Cann2024-11-28T14:07:46+00:00April 11th, 2022|Article, Investment|
